Wayne Burton, MD, former global corporate medical director for American Express discusses the impact that workers with migraine have on employers.
Wayne Burton, MD, former global corporate medical director for American Express discusses the impact that workers with migraine have on employers.
Transcript:
What kind of impact do workers with migraine have on employers? Do employers see a loss of revenue or productivity? How can this be mitigated?
Migraine is extremely important to employers because if you think about migraine headaches, they effect people basically between age 25 and 55—prime age group for workers. Eighteen percent are women, about 6% are men, and it has significant impacts on on-the-job productivity, or so-called presenteeism, as well as direct costs, [like] medical costs [and] pharmacy costs. So, it’s an exceedingly important medical condition for employers.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More